Medicine – Renovascular Disease

Renovascular disease refers to narrowing or obstruction of the renal arteries or their major branches, resulting in reduced renal perfusion. The most important clinical consequence is renovascular hypertension, but severe disease can also cause recurrent pulmonary oedema, progressive chronic kidney disease, or acute kidney injury.

The two major causes are:

Atherosclerotic renal artery stenosis, usually in older patients with widespread vascular disease.

Fibromuscular dysplasia, more often seen in younger patients, especially women.

1. Association with Generalised Vascular Disease

Atherosclerotic renovascular disease is strongly associated with:

Coronary artery disease.

Peripheral arterial disease.

Cerebrovascular disease.

Aortic atherosclerosis.

This is because renal artery stenosis is often one manifestation of widespread systemic atherosclerosis.

2. Why Prognosis May Be Poor

Patients with atherosclerotic renovascular disease often have substantial cardiovascular comorbidity.

Therefore, prognosis may be adversely affected by:

Myocardial infarction.

Stroke.

Heart failure.

Peripheral vascular disease.

Progressive kidney disease.

The poor prognosis is often related not only to the renal artery lesion itself, but also to the patient’s overall cardiovascular disease burden.

3. Renovascular Hypertension

Reduced renal perfusion stimulates the:

Renin–angiotensin–aldosterone system.

The sequence is:

Renal artery narrowing → reduced renal perfusion → renin release → angiotensin II → vasoconstriction + aldosterone release → hypertension.

This produces:

Renovascular hypertension.

4. Clinical Clues to Renovascular Hypertension

Renovascular hypertension should be considered when hypertension is:

Severe.

Resistant to multiple antihypertensive drugs.

Sudden in onset.

Worsening after previously stable control.

Associated with unexplained renal impairment.

5. Age Pattern

The age of onset can provide a clue.

Older patient + widespread atherosclerosis → think atherosclerotic renal artery stenosis.

Younger patient, especially a woman + hypertension → think fibromuscular dysplasia.

6. Flash Pulmonary Oedema

One of the most important clinical presentations is:

Recurrent flash pulmonary oedema.

This is particularly associated with:

Bilateral severe renal artery stenosis

or

Severe stenosis affecting a solitary functioning kidney.

7. Why Flash Pulmonary Oedema Occurs

Reduced renal perfusion activates:

RAAS.

This causes:

Sodium retention.

Water retention.

Vasoconstriction.

Rapid elevation of blood pressure.

The result can be sudden fluid redistribution and:

Acute pulmonary oedema.

A useful association is:

Recurrent unexplained flash pulmonary oedema + severe hypertension → consider renovascular disease.

8. Chronic Kidney Disease

Renovascular disease can lead to progressive:

Chronic kidney disease, or CKD.

The older term:

CRF – chronic renal failure

is now generally replaced by:

CKD.

Long-standing reduction in renal perfusion may lead to:

Ischaemic nephropathy.

9. Ischaemic Nephropathy

Ischaemic nephropathy refers to chronic renal dysfunction caused by inadequate renal blood flow, usually due to significant renal artery stenosis.

Over time, the affected kidney may become:

Smaller.

Atrophic.

Poorly functioning.

10. End-Stage Kidney Disease

Severe bilateral renovascular disease can eventually contribute to:

End-stage kidney disease, or ESKD.

The older term:

ESRF

is now usually replaced by:

ESKD.

However, progression to kidney failure is not inevitable in every patient with renal artery stenosis.

11. Acute Kidney Injury after ACE Inhibitors or ARBs

An important clinical clue is deterioration in renal function after starting:

An ACE inhibitor

or

An angiotensin II receptor blocker, or ARB.

This is particularly concerning for:

Bilateral renal artery stenosis

or

Stenosis of the renal artery supplying a solitary functioning kidney.

12. Why ACE Inhibitors Can Cause AKI

In renal artery stenosis, renal perfusion pressure is reduced.

The kidney partly maintains GFR by using:

Angiotensin II-mediated constriction of the efferent arteriole.

This helps preserve pressure within the glomerulus.

13. Effect of ACE Inhibition

ACE inhibitors and ARBs reduce the effect of angiotensin II.

Therefore:

Efferent arteriole dilates → intraglomerular pressure falls → GFR decreases.

If both kidneys depend heavily on angiotensin II to maintain filtration, a marked rise in creatinine can occur.

14. High-Yield Pattern

Remember:

ACE inhibitor/ARB + sudden significant rise in creatinine → think bilateral renal artery stenosis.

This does not mean every small creatinine rise indicates renovascular disease.

A modest rise can occur normally after RAAS blockade, but a large or rapidly progressive increase should prompt reassessment.

15. Unilateral Renal Artery Stenosis

In unilateral disease, the unaffected kidney can often maintain overall renal function.

Therefore, ACE inhibitors may still be used in selected patients with:

Unilateral renal artery stenosis

provided renal function and potassium are monitored carefully.

16. Bilateral Renal Artery Stenosis

In significant bilateral disease, both kidneys may depend on angiotensin II to maintain glomerular filtration.

Therefore, ACE inhibitors and ARBs can cause:

Marked deterioration in renal function.

This makes bilateral disease clinically much more important.

17. Renal Bruit

A possible physical examination finding is:

Abdominal or flank bruit.

A renal artery bruit may support suspicion of renovascular disease, especially when hypertension is severe or resistant.

However, its absence does not exclude renal artery stenosis.

18. Atherosclerotic Renal Artery Stenosis

This is the most common form of renovascular disease in older adults.

Typical risk factors include:

Smoking.

Hypertension.

Diabetes.

Hyperlipidaemia.

Established atherosclerotic cardiovascular disease.

Lesions commonly involve the:

Ostium or proximal renal artery.

19. Fibromuscular Dysplasia

Fibromuscular dysplasia is a non-atherosclerotic, non-inflammatory arterial disease.

It typically affects:

Younger or middle-aged women.

It commonly involves the:

Mid-to-distal renal artery.

20. String-of-Beads Appearance

Fibromuscular dysplasia can produce the classic angiographic:

“String-of-beads” appearance.

This reflects alternating areas of:

Arterial stenosis

and

Aneurysmal dilatation.

21. Ultrasound

Renal ultrasonography may show:

Asymmetrical kidney size.

The kidney supplied by a chronically stenosed renal artery may become:

Smaller and atrophic.

This can be an important clue.

22. Duplex Doppler Ultrasound

A more useful modern vascular test is:

Renal artery duplex Doppler ultrasonography.

This can estimate blood-flow velocity and help detect haemodynamically significant stenosis.

Advantages include:

No ionising radiation.

No iodinated contrast.

Limitations include:

Operator dependence.

Difficulty in obesity or bowel gas.

23. Captopril Renogram

The original notes list:

Captopril renography.

This was historically used to identify functionally significant renal artery stenosis.

However, it is now used much less commonly because:

CT angiography

and

MR angiography

usually provide better anatomical assessment.

24. CT Angiography

CT angiography, or CTA, provides detailed imaging of the renal arteries.

It can demonstrate:

Location of stenosis.

Severity of narrowing.

Associated aortic atherosclerosis.

Its limitations include exposure to:

Ionising radiation

and

Iodinated contrast.

25. MR Angiography

MR angiography, or MRA, can also visualise the renal arteries.

It may be useful when CTA is unsuitable.

However, image quality, availability, renal function, and contrast considerations influence the choice of modality.

26. Conventional Angiography

Catheter-based renal angiography remains the anatomical reference standard.

However, because it is invasive, it is usually reserved for situations where:

Diagnosis remains uncertain

or

An endovascular intervention is being considered.

27. Investigation Strategy

A simplified modern approach is:

Clinical suspicion → renal ultrasound/duplex Doppler → CTA or MRA if appropriate → invasive angiography when intervention is planned or uncertainty remains.

The exact sequence depends on:

Renal function.

Contrast risk.

Local expertise.

Likelihood of intervention.

28. Treatment Principles

Treatment depends on:

Cause of the stenosis.

Severity of hypertension.

Renal function.

Presence of recurrent pulmonary oedema.

Anatomy of the lesion.

Whether the patient has fibromuscular dysplasia or atherosclerotic disease.

29. Medical Therapy

For many patients with atherosclerotic renal artery stenosis, the main treatment is:

Optimal medical therapy.

This includes:

Blood-pressure control.

Lipid lowering.

Antiplatelet therapy when indicated for atherosclerotic disease.

Smoking cessation.

Diabetes management.

30. Antihypertensive Therapy

Blood pressure should be treated appropriately.

Possible agents include:

ACE inhibitors or ARBs in selected patients.

Calcium-channel blockers.

Beta blockers.

Diuretics.

Choice depends on renal function, potassium, unilateral versus bilateral disease, and clinical tolerance.

31. ACE Inhibitors and ARBs

ACE inhibitors or ARBs can be very effective in renovascular hypertension, particularly with unilateral disease.

However:

Renal function and serum potassium must be monitored.

A marked creatinine rise should raise concern for:

Bilateral severe stenosis

or

Stenosis of a solitary functioning kidney.

32. Aspirin

The original treatment list includes:

Aspirin.

This is not used because it directly treats the renal artery stenosis.

It may be used because many patients have:

Atherosclerotic cardiovascular disease.

Thus antiplatelet therapy is used according to overall cardiovascular indications.

33. Lipid-Lowering Therapy

Statin therapy is important in atherosclerotic renovascular disease because these patients commonly have widespread vascular disease.

The aim is to reduce:

Cardiovascular events.

Stroke risk.

Progression of systemic atherosclerosis.

34. Angioplasty

Percutaneous transluminal renal angioplasty may be used to restore renal artery blood flow.

Its role differs greatly depending on the underlying cause.

35. Fibromuscular Dysplasia and Angioplasty

In fibromuscular dysplasia:

Angioplasty without routine stenting

is often an effective treatment.

It may significantly improve or occasionally cure:

Hypertension.

This is one of the clearest indications for renal artery angioplasty.

36. Atherosclerotic Renal Artery Stenosis and Stenting

In atherosclerotic renal artery stenosis, routine angioplasty and stenting are not beneficial for every patient compared with good medical therapy.

Therefore, revascularisation is generally reserved for selected high-risk situations.

37. When Revascularisation May Be Considered

Important situations include:

Recurrent flash pulmonary oedema.

Recurrent unexplained heart failure associated with severe renal artery stenosis.

Rapidly declining kidney function with haemodynamically significant bilateral disease.

Severe resistant hypertension despite appropriate medical treatment.

Significant stenosis of a solitary functioning kidney.

38. Renal Artery Stenting

When intervention is chosen for:

Atherosclerotic ostial renal artery stenosis,

angioplasty may be combined with:

Stent placement.

The purpose is to maintain vessel patency after dilation.

39. Surgical Revascularisation

Open surgical reconstruction is much less commonly required today.

It may be considered in selected patients with:

Complex vascular anatomy.

Concurrent aortic surgery.

Failed endovascular treatment.

40. Renovascular Disease – Note Form

Association:

Strongly associated with systemic atherosclerotic vascular disease.

Prognosis:

Often determined by high cardiovascular comorbidity.

Main presentation:

Hypertension.

Especially severe, resistant, abrupt, or worsening hypertension.

Important clue:

Recurrent flash pulmonary oedema.

Think bilateral severe renal artery stenosis.

Renal consequences:

AKI.

CKD.

Ischaemic nephropathy.

Occasionally ESKD.

ACE inhibitor clue:

Large creatinine rise after ACE inhibitor or ARB suggests bilateral renal artery stenosis or stenosis of a solitary functioning kidney.

Ultrasound:

May show asymmetrical renal size.

Duplex Doppler can assess renal artery blood flow.

Captopril renogram:

Historical test.

Now used much less often.

CTA/MRA:

Important non-invasive anatomical imaging.

Conventional angiography:

Invasive reference test, especially when intervention is contemplated.

Treatment:

Antihypertensive therapy.

Statin therapy.

Antiplatelet therapy when cardiovascular indications exist.

Smoking cessation.

Risk-factor modification.

Fibromuscular dysplasia:

Angioplasty is often effective.

Stent usually not routinely required.

Atherosclerotic stenosis:

Medical treatment is first-line in many patients.

Angioplasty/stenting reserved for selected high-risk presentations.

41. Important Corrections to the Original Notes

The original note lists:

“Angioplasty ± stenting”

as a general treatment.

This needs qualification.

For fibromuscular dysplasia, angioplasty is an important treatment.

For atherosclerotic renal artery stenosis, routine stenting is not indicated for every patient and is usually reserved for selected cases.

The original:

“Captopril renogram”

is now less commonly used.

Modern evaluation more often relies on:

Duplex Doppler ultrasound + CT angiography or MR angiography.

The older terms:

ARF, CRF and ESRF

are better replaced with:

AKI – acute kidney injury.

CKD – chronic kidney disease.

ESKD – end-stage kidney disease.

Key Clinical Pattern

Think of renovascular disease when there is:

SEVERE OR RESISTANT HYPERTENSION + GENERALIZED ATHEROSCLEROSIS.

A particularly important clue is:

FLASH PULMONARY OEDEMA + HYPERTENSION → THINK BILATERAL RENAL ARTERY STENOSIS.

Also remember:

ACEi/ARB → LARGE CREATININE RISE → THINK BILATERAL RENAL ARTERY STENOSIS OR STENOSIS OF A SOLITARY KIDNEY.

For causes:

OLDER + ATHEROSCLEROSIS → ATHEROSCLEROTIC RENAL ARTERY STENOSIS.

YOUNGER WOMAN + HYPERTENSION + STRING OF BEADS → FIBROMUSCULAR DYSPLASIA.

And for management:

ATHEROSCLEROTIC DISEASE → MEDICAL THERAPY FIRST IN MANY PATIENTS.

FIBROMUSCULAR DYSPLASIA → ANGIOPLASTY OFTEN EFFECTIVE.